Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald M Goldenberg

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Diabetes Care|September 19, 2025
GLP-1 Receptor Agonists Help LegsRonald M Goldenberg, Subodh Verma
Current Medical Research and Opinion|August 25, 2017
Adding prandial GLP-1 receptor agonists to basal insulin: a promising option for type 2 diabetes therapyRonald M Goldenberg, Lori Berard
Canadian Journal of Diabetes|September 26, 2017
The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 DiabetesOren Steen, Ronald M Goldenberg
Diabetes Care|May 15, 2023
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390Ronald M Goldenberg, Akshay B Jain
Touchreviews in Endocrinology|June 14, 2023
Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 DiabetesHarpreet S Bajaj, Ronald M Goldenberg
Current Opinion in Cardiology|October 4, 2023
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-agonists for cardioprotection, type 2 diabetes and obesity: a review of mechanisms and clinical dataRonald M Goldenberg, Hwee Teoh, Subodh Verma
Diabetes, Obesity & Metabolism|May 11, 2026
Tirzepatide Versus Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes With Established Cardiovascular Disease: An Indirect Treatment Comparison Meta-AnalysisRonald M Goldenberg, Jill Trinacty, Christine Ibrahim
Diabetes, Obesity & Metabolism|August 4, 2025
Glucagon-like peptide-1 receptor agonists and the risk of nonarteritic anterior ischaemic optic neuropathy: A systematic review and meta-analysis of observational studiesRonald M Goldenberg, Ronnie Aronson, Jill Trinacty
Acta Cardiologica|September 1, 2005
Cardiac arrest following anaesthetic induction in a world-class bodybuilderAllison Angelilli, Edward S Katz, Ronald M Goldenberg
Canadian Journal of Diabetes|November 14, 2016
Can the Combination of Incretin Agents and Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Reconcile the Yin and Yang of Glucagon?Ronald M Goldenberg, Subodh Verma, Bruce A Perkins, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Diabetes Care|September 19, 2025
GLP-1 Receptor Agonists Help LegsRonald M Goldenberg, Subodh Verma
Current Medical Research and Opinion|August 25, 2017
Adding prandial GLP-1 receptor agonists to basal insulin: a promising option for type 2 diabetes therapyRonald M Goldenberg, Lori Berard
Canadian Journal of Diabetes|September 26, 2017
The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 DiabetesOren Steen, Ronald M Goldenberg
Diabetes Care|May 15, 2023
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390Ronald M Goldenberg, Akshay B Jain
Touchreviews in Endocrinology|June 14, 2023
Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 DiabetesHarpreet S Bajaj, Ronald M Goldenberg
Current Opinion in Cardiology|October 4, 2023
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-agonists for cardioprotection, type 2 diabetes and obesity: a review of mechanisms and clinical dataRonald M Goldenberg, Hwee Teoh, Subodh Verma
Diabetes, Obesity & Metabolism|May 11, 2026
Tirzepatide Versus Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes With Established Cardiovascular Disease: An Indirect Treatment Comparison Meta-AnalysisRonald M Goldenberg, Jill Trinacty, Christine Ibrahim
Diabetes, Obesity & Metabolism|August 4, 2025
Glucagon-like peptide-1 receptor agonists and the risk of nonarteritic anterior ischaemic optic neuropathy: A systematic review and meta-analysis of observational studiesRonald M Goldenberg, Ronnie Aronson, Jill Trinacty
Acta Cardiologica|September 1, 2005
Cardiac arrest following anaesthetic induction in a world-class bodybuilderAllison Angelilli, Edward S Katz, Ronald M Goldenberg
Canadian Journal of Diabetes|November 14, 2016
Can the Combination of Incretin Agents and Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Reconcile the Yin and Yang of Glucagon?Ronald M Goldenberg, Subodh Verma, Bruce A Perkins, et al.
Pageof 5